Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medline Inc. - Class A common stock
(NQ:
MDLN
)
34.81
-0.26 (-0.74%)
Streaming Delayed Price
Updated: 9:50 AM EDT, Sep 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medline Inc. - Class A common stock
< Previous
1
2
3
4
Next >
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations
June 17, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations
June 17, 2026
NEW YORK, NY - June 17, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via
TheNewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Industries, Inc. - MDLN
June 16, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
June 16, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Medline (NASDAQ:MDLN) Q1 Earnings: Revenue Beats, But Profits Slip on Tariff and Cost Pressures
↗
May 06, 2026
Via
Chartmill
Medline Inc. (NASDAQ:MDLN) Reports Q4 Revenue Beat but EPS Miss Amid Margin Pressure
↗
February 25, 2026
Via
Chartmill
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
June 16, 2026
NEW YORK, NY - June 16, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via
TheNewswire.com
Kaplan Fox Alerts Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Potential Securities Law Violations
June 15, 2026
NEW YORK, NY - June 15, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN).
Via
TheNewswire.com
Kaplan Fox Alerts Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Potential Securities Law Violations
June 15, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm
June 10, 2026
From
Schall Law
Via
GlobeNewswire
Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
June 09, 2026
From
Glancy Prongay Wolke & Rotter LLP
Via
Business Wire
Medline Industries, Inc. (MDLN) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
June 09, 2026
From
Law Offices of Howard G. Smith
Via
Business Wire
Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
June 08, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Why Symbotic Stock Slumped 21% in May And Just Hit a 2026 Low
↗
June 08, 2026
Is something seriously wrong with the automation expert, or is this a market overreaction and an opportunity to buy?
Via
The Motley Fool
Topics
Economy
Medline Inc. announces closing of upsized secondary offering of Class A common stock
May 28, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline announces participation in upcoming investor conferences
May 27, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Inc. announces pricing of upsized secondary offering of Class A common stock
May 21, 2026
From
Medline Inc.
Via
GlobeNewswire
Monashee Scales Back Its Bet on Structure Therapeutics
↗
May 20, 2026
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
Via
The Motley Fool
Topics
Regulatory Compliance
Medline Inc. announces launch of secondary offering of Class A common stock
May 20, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Reports First Quarter 2026 Results
May 06, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
March 10, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Inc. announces pricing of secondary offering of class A common stock
March 04, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Inc. announces launch of secondary offering of Class A common stock
March 03, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline Reports Fourth Quarter and Full Year 2025 Results
February 25, 2026
From
Medline Inc.
Via
GlobeNewswire
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
February 18, 2026
From
Medline Inc.
Via
GlobeNewswire
Symbotic Could Be a Massive Breakout Stock in 2026 After a 150% Surge in 2025
↗
February 05, 2026
Symbotic's big growth moves of 2025 should propel the company to new highs.
Via
The Motley Fool
How the Largest IPO of 2025 Could Be Healthy for Your Portfolio
↗
February 05, 2026
Medline is an appealing investment candidate – it has solid growth, operates in a steady industry, and a storied history.
Via
The Motley Fool
Topics
Economy
Initial Public Offering
Medline to report fourth quarter and full year 2025 results on February 25, 2026
January 28, 2026
From
Medline Inc.
Via
GlobeNewswire
A Fresh IPO That Long-Term Investors Shouldn’t Ignore
↗
January 14, 2026
Via
MarketBeat
Topics
Initial Public Offering
Motley Fool Money: The Most Shocking Stories of 2025
↗
January 05, 2026
Do you remember all of the surprises investors got in 2025? We had tariffs, AI upheaval, and even gold having a great year.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
World Trade
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
